ジゴキシン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "ジゴキシン" in Japanese language version.

refsWebsite

Global rank Japanese rank

6nih.gov

4^th place

24^th place

4doi.org

2^nd place

6^th place

3harvard.edu

18^th place

107^th place

1fda.gov

447^th place

1,043^rd place

1web.archive.org

1^st place

1usrecallnews.com

low place

1pnas.org

1,293^rd place

1,250^th place

1thelancet.com

2,393^rd place

4,709^th place

doi.org

Zhang, H.; Qian, D. Z.; Tan, Y. S.; Lee, K.; Gao, P.; Ren, Y. R.; Rey, S.; Hammers, H. et al. (2008). “Inaugural Article: Digoxin and other cardiac glycosides inhibit HIF-1 synthesis and block tumor growth”. Proceedings of the National Academy of Sciences 105 (50): 19579–19586. Bibcode: 2008PNAS..10519579Z. doi:10.1073/pnas.0809763105. PMC 2604945. PMID 19020076.
Lopez-Lazaro M (March 2009). “Digoxin, HIF-1, and cancer” (pdf). PNAS 106 (9): E26. Bibcode: 2009PNAS..106...26L. doi:10.1073/pnas.0813047106. PMC 2651277. PMID 19240208.
Zhang, H.; Semenza, G. L. (2009). “Reply to Lopez-Lazaro: Evidence that digoxin inhibits human cancer”. Proceedings of the National Academy of Sciences 106 (9): E27. Bibcode: 2009PNAS..106...27Z. doi:10.1073/pnas.0900125106.
Washam JB, Stevens SR, Lokhnygina Y, Halperin JL, Breithardt G, Singer DE et al. (2015). “Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).”. Lancet 385 (9985): 2363-70. doi:10.1016/S0140-6736(14)61836-5. PMID 25749644.

fda.gov

“Recalls, Market Withdrawals & Safety Alerts”. FDA (2008年10月15日). 2011年11月8日閲覧。

harvard.edu

ui.adsabs.harvard.edu

Zhang, H.; Qian, D. Z.; Tan, Y. S.; Lee, K.; Gao, P.; Ren, Y. R.; Rey, S.; Hammers, H. et al. (2008). “Inaugural Article: Digoxin and other cardiac glycosides inhibit HIF-1 synthesis and block tumor growth”. Proceedings of the National Academy of Sciences 105 (50): 19579–19586. Bibcode: 2008PNAS..10519579Z. doi:10.1073/pnas.0809763105. PMC 2604945. PMID 19020076.
Lopez-Lazaro M (March 2009). “Digoxin, HIF-1, and cancer” (pdf). PNAS 106 (9): E26. Bibcode: 2009PNAS..106...26L. doi:10.1073/pnas.0813047106. PMC 2651277. PMID 19240208.
Zhang, H.; Semenza, G. L. (2009). “Reply to Lopez-Lazaro: Evidence that digoxin inhibits human cancer”. Proceedings of the National Academy of Sciences 106 (9): E27. Bibcode: 2009PNAS..106...27Z. doi:10.1073/pnas.0900125106.

nih.gov

pnas.org

Lopez-Lazaro M (March 2009). “Digoxin, HIF-1, and cancer” (pdf). PNAS 106 (9): E26. Bibcode: 2009PNAS..106...26L. doi:10.1073/pnas.0813047106. PMC 2651277. PMID 19240208.

thelancet.com

Washam JB, Stevens SR, Lokhnygina Y, Halperin JL, Breithardt G, Singer DE et al. (2015). “Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).”. Lancet 385 (9985): 2363-70. doi:10.1016/S0140-6736(14)61836-5. PMID 25749644.

usrecallnews.com

“Urgent Digitek Digoxin Recall”. U.S. Recall News. (2008年4月28日). オリジナルの2008年5月4日時点におけるアーカイブ。 2009年7月25日閲覧。

web.archive.org

“Urgent Digitek Digoxin Recall”. U.S. Recall News. (2008年4月28日). オリジナルの2008年5月4日時点におけるアーカイブ。 2009年7月25日閲覧。